Pharmatica

AI in Pharma: Why the Future of Healthcare Starts With Patients, Not Tech

Kate O’Reilly, President & Chair of the Healthcare Businesswomen’s Association (HBA) Dublin-Ireland Chapter & Healthcare Transformation Partner at Roche, discusses AI in pharma, patient engagement, and the future of healthcare innovation.

In the recent episode of The Chain Reaction podcast, Nour AlSaleh, Founder and CEO of Veragence Pharma Consultancy, sat down with host Shubhangi Dua, Podcast Producer and B2B Journalist at Pharmatica.io and EM360Tech. AlSaleh shares her expertise on maintaining data integrity in this new era of AI and changing policies.

In the recent episode of the Digital Pulse podcast, host Shubhangi Dua, Podcast Producer and B2B Journalist, sat down with Lara Masad, an AI and Data Innovation independent consultant, to clarify the key distinctions in AI and machine learning models. Furthermore, Masad explains how pharmaceutical companies benefit from using AI models.

Trisha Pillay speaks with Judit Mora, CEO of Nuumad, on Digital Pulse discussing pharmacy innovation, market access barriers, and new models for faster patient access to healthcare.

Trisha Pillay speaks with Dineshree Naiker, co-founder of Umsebe Healthcare, on Chain Reaction discussing regulatory leadership, pharmaceutical supply chains, and improving patient access to medicines.

Trisha Pillay interviews Émile Malan, CEO of Vicore Health, on Chain Reaction about pharmaceutical supply chains, AI, and healthcare resilience after COVID-19.

Trisha Pillay speaks with Maarten Schelles, CTO and Co-Founder of ReVision, during a Clinical Compass podcast about cortical brain implants for vision restoration and how direct visual cortex stimulation is creating new possibilities for treating blindness.

Trisha Pillay speaks with Dr David Hayes, Chief Medical Officer at BIOTRONIK, during a Clinical Compass podcast recording discussing how clinical research shapes cardiac device innovation and why it must be embedded early in product development.

Exclusive Pharmatica Content

Explore expert-led podcasts, pharmaceutical intelligence, life sciences insights and research-driven analysis from leading industry voices. Pharmatica delivers trusted biotech news, drug development trends and commercial intelligence for professionals across the pharmaceutical sector.

Nicole Dale

Anthropic’s Big AI Drug Discovery Announcement

Anthropic drug discovery programme combines AI research with pharmaceutical R&D as a scientist uses advanced analytics to accelerate neglected disease drug discovery.

Anthropic's new drug discovery programme marks a strategic shift from sole AI software provider to active R&D participant. Here's what it means for pharmaceutical innovation.

Shubhangi Dua

How AI Is Reshaping Data Integrity in Pharma Manufacturing

Veragence CEO Nour AlSaleh discusses how AI is transforming data integrity in pharma manufacturing, regulatory compliance, the "human-in-the-loop" requirement, and patient safety in the era of AI-driven GxP systems.

Nicole Dale

Digital Measures in Clinical Trials: FDA vs EMA Pathways

Clinician reviewing digital measures in clinical trials on a tablet, illustrating regulatory acceptance of digital health technologies, digital biomarkers, and FDA and EMA qualification pathways for modern clinical research.

Explore how novel digital measures gain regulatory acceptance in clinical trials, comparing FDA-structured pathways with EMA engagement-led frameworks.

Nicole Dale

FDA Draft Guidance on Gene Editing Safety (2026)

DNA double helix illustrating the FDA gene editing draft guidance 2026, highlighting next-generation sequencing (NGS) safety assessment, off-target editing analysis, genomic integrity testing, and regulatory requirements for cell and gene therapy development.

The FDA’s 2026 gene editing draft guidance could change your regulatory strategy. Explore the new NGS requirements for cell and gene editing therapies.

Nicole Dale

Next-Generation Sequencing for Cell Line Development in Biologics Manufacturing

Laboratory illustrating next-generation sequencing cell line development for biologics manufacturing, highlighting DNA analysis, genomic characterisation, bioprocess development, Quality by Design, and pharmaceutical manufacturing innovation.

Discover how next-generation sequencing in cell line development is improving biologics manufacturing, quality control, and regulatory confidence.

Shubhangi Dua

AI in Pharma: Why the Future of Healthcare Starts With Patients, Not Tech

Shubhangi Dua

AI in Pharma: Hype vs. What Actually Works

Expert Lara Masad explains why pharma leaders miscalculate AI investments and how to build a defensible validation strategy.

Nicole Dale

Optimising Preclinical Pharmacology for Oncology NMEs

Oncology researcher performing preclinical pharmacology testing for new molecular entities (NMEs), illustrating oncology drug development, translational research, biomarker discovery, and advanced preclinical model optimisation.

Over 90% of oncology NMEs that succeed in animal studies fail in clinical trials. This analysis examines how to optimise preclinical pharmacology models to improve translational success.

Nicole Dale

Could Biological Age Become Pharma's Most Important Biomarker?

Biomarkers biological age illustration showing a human silhouette, DNA strands and AI-powered health analysis representing precision medicine and longevity research.

New research shows biomarkers of biological age predict mortality and hospitalisation better than chronological age, opening new opportunities for pharma innovation.

Nicole Dale

FDA 2026 Draft Guidance on Alternatives to Animal Testing

Illustration representing FDA alternatives to animal testing, featuring laboratory research, organ-on-chip technology, genetic science, AI-enabled drug discovery and next-generation pharmaceutical testing methods.

The FDA's March 2026 draft guidance on alternatives to animal testing marks a pivotal shift in preclinical drug development. Here's what pharma R&D teams need to know.

Nicole Dale

Why Europe's Heatwave Is an Important Pharma Cold Chain Risk

Visual representation of pharmaceutical cold chain risk showing refrigerated medicine storage exposed to extreme heat conditions, highlighting temperature-sensitive pharmaceutical supply chain challenges during climate-related disruptions.

Europe's 2026 heatwave is pushing pharmaceutical cold chain risk to the limit. Here is what supply chain leaders must do to protect drug integrity now.

Nicole Dale

Midjourney Medical: The AI Image Pioneer’s Unexpected Healthcare Play

Digital human body visualisation representing Midjourney Medical, showcasing AI-powered whole-body imaging, preventative healthcare technology, advanced medical scanning, and personalised health intelligence.

Midjourney Medical is bringing AI, full-body imaging, and preventative care together. Could this unexpected move reshape healthcare delivery?

Content type

Topic

Articles, expert interviews, and insights from life sciences leaders

AI in Pharma: Why the Future of Healthcare Starts With Patients, Not Tech

Anthropic’s Big AI Drug Discovery Announcement

How AI Is Reshaping Data Integrity in Pharma Manufacturing

Digital Measures in Clinical Trials: FDA vs EMA Pathways

FDA Draft Guidance on Gene Editing Safety (2026)

Next-Generation Sequencing for Cell Line Development in Biologics Manufacturing

AI in Pharma: Why the Future of Healthcare Starts With Patients, Not Tech

AI in Pharma: Hype vs. What Actually Works

Optimising Preclinical Pharmacology for Oncology NMEs

Could Biological Age Become Pharma's Most Important Biomarker?

FDA 2026 Draft Guidance on Alternatives to Animal Testing

Why Europe's Heatwave Is an Important Pharma Cold Chain Risk

Midjourney Medical: The AI Image Pioneer’s Unexpected Healthcare Play